Get Premium to unlock powerful stock data
NAS:GRNA (USA)  
GreenLight Biosciences Inc logo

GreenLight Biosciences Inc

$ 2.72 -0.3 (-9.93%) 10:08 PM EST
P/E:
9.86
P/B:
5.24
Market Cap:
$ 335.10M
Enterprise V:
$ 285.41M
Volume:
1.41M
Avg Vol (2M):
273.33K
Volume:
1.41M
Market Cap $:
335.10M
PE Ratio:
9.86
Avg Vol (2-Month):
273.33K
Enterprise Value $:
285.41M
PB Ratio:
5.24
GF Score:
Year:
EMBED
To
10Y: -%
Above Low: +NaN%
Below High: NaN%

Business Description

GreenLight Biosciences Inc
NAICS : 541714 SIC : 2834
200 Boston Avenue, Suite 3100, Medford, MA, USA, 02155
Description
GreenLight Biosciences Inc is a pre-commercial stage synthetic biology company with a proprietary cell-free ribonucleic acid production platform for the discovery, development, and commercialization of high-performing products to promote healthier plants, foods, and people. The company is developing RNA products for plant and life science applications to advance crop management, plant protection, animal health, vaccine development, and pandemic preparation.
Name Current Vs Industry Vs History
Cash-To-Debt 2.48
Equity-to-Asset 0.52
Debt-to-Equity 0.53
Debt-to-EBITDA 1.2
Interest Coverage 23.27
Piotroski F-Score N/A/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 0
Distress
Grey
Safe
Beneish M-Score 0
Manipulator
Not Manipulator

Growth Rank

Name Current Vs Industry Vs History

Momentum Rank

Name Current Vs Industry Vs History
5-Day RSI 13.88
9-Day RSI 19.18
14-Day RSI 23.17

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 3.28
Quick Ratio 3.28
Cash Ratio 2.82

Dividend & Buy Back

Name Current Vs Industry Vs History

Financials (Next Earnings Date:2022-08-31 Est.)

GRNA's 30-Y Financials

Guru Trades

See Details
To
EMBED
SAVE

Insider Trades

See Details
To
EMBED
SAVE

Gurus Latest Trades with NAS:GRNA

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To
EMBED
SAVE
Dividend
To
EMBED
SAVE

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

EMBED

Valuation Box

Year:
EMBED

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 0
EPS (TTM) ($) 0.276
Beta 0
Volatility % 0
14-Day RSI 23.17
14-Day ATR ($) 0.693558
20-Day SMA ($) 5.2765
12-1 Month Momentum % 0
52-Week Range ($) 2.72 - 15.8
Shares Outstanding (Mil) 123.2

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 9999
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

GreenLight Biosciences Inc Filings

Document Form Filing Date
No Filing Data

Headlines

See More